학술논문
Temporal trends of adverse events and costs of nivolumab plus ipilimumab versus sunitinib in advanced renal cell carcinoma
Document Type
Article
Author
Source
In: Future Oncology . (Future Oncology, March 2022, 18(10):1219-1234)
Subject
Language
English
ISSN
17448301
14796694
14796694